ArticleOncotarget2017

Elevation of MAP17 enhances the malignant behavior of cells via the Akt/mTOR pathway in hepatocellular carcinoma.

Xinhuang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.